Trials / Completed
CompletedNCT01387698
Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis
Observatoire Prospectif, Longitudinal Dans la Prise en Charge Thérapeutique de La Rectocolite Hémorragique légère à Modérée
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 812 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to confirm the long-term efficacy (remission and maintenance in remission) of current validated treatments. Each patient will be followed during 3 years in this non-interventional trial.
Conditions
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2011-07-04
- Last updated
- 2015-10-29
Locations
158 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01387698. Inclusion in this directory is not an endorsement.